Tech Center 3700 • Art Units: 1631 1671 1687 3781
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18041362 | MONITORING AND CONTROLLING BACTERIOPHAGE PRESSURE | Non-Final OA | DSM IP ASSETS B.V. |
| 19342186 | MODEL-IN-THE-LOOP SYNTHETIC BIOLOGY | Non-Final OA | X Development LLC |
| 17574915 | DISEASE REPRESENTATION AND CLASSIFICATION WITH MACHINE LEARNING | Final Rejection | X Development LLC |
| 17406948 | IDENTIFICATION AND USE OF CIRCULATING NUCLEIC ACID TUMOR MARKERS | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17937259 | IDENTIFYING PRESENCE AND COMPOSITION OF CELL-FREE NUCLEIC ACIDS | Non-Final OA | Regents of the University of Minnesota |
| 17371850 | IN VITRO EVALUATION METHOD FOR RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH SMOKING OR INHALATION | Final Rejection | Japan Tobacco Inc. |
| 17821916 | UTILIZING DEEP REINFORCEMENT LEARNING FOR DISCOVERING NEW COMPOUNDS | Non-Final OA | Accenture Global Solutions Limited |
| 17686953 | Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity | Final Rejection | Laboratory Corporation of America Holdings |
| 18168870 | SYSTEMS AND METHODS FOR PATIENT IMAGE PROCESSING TO EVALUATE TISSUE FUNCTION | Non-Final OA | HeartFlow, Inc. |
| 17399704 | SYSTEMS AND METHODS FOR PATIENT-SPECIFIC IMAGING AND MODELING OF DRUG DELIVERY | Non-Final OA | HeartFlow, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy